AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LORAZEPAM
26 registrations across 8 African markets— 20 active
Markets with LORAZEPAM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| APO-LORAZEPAM TABLET; ORAL | 🇿🇼Zimbabwe | APOTEX INC. | active | Dec 2027 |
| TEMESTA 2,5MG COMPRIME SECABLE BOITE DE 30 | 🇨🇮Côte d'Ivoire | NEURAXPHARM | expired | Jan 2020 |
| TEMESTA 1MG COMPRIME SECABLE BOITE DE 30 | 🇨🇮Côte d'Ivoire | NEURAXPHARM | expired | Jan 2020 |
| TEMESTA Comprimé sécable / 2.5 MG | 🇹🇳Tunisia | NEURAXPHARM FRANCE | expired | Jan 2007 |
| TEMESTA Comprimé sécable / 1 MG | 🇹🇳Tunisia | NEURAXPHARM FRANCE | expired | Jan 2007 |
| ATIVAN 1MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2004 |
| ATIVAN 2.5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2002 |
| ATIVAN INJECTION | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ATIVAN SL 1 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ATIVAN 2,5 mg* | 🇿🇦South Africa | AKROMED PRODUCTS (PTY) LTD | active | Jan 1900 |
| ATIVAN 0,5 mg* | 🇿🇦South Africa | AKROMED PRODUCTS (PTY) LTD | active | Jan 1900 |
| TRANQIPAM - 1 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ATIVAN SL 2 mg* | 🇿🇦South Africa | AKROMED PRODUCTS (PTY) LTD | active | Jan 1900 |
| TRANQIPAM - 2,5 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ATIVAN 1 mg* | 🇿🇦South Africa | AKROMED PRODUCTS (PTY) LTD | active | Jan 1900 |
| TEMESTA COMPRIME SECABLE | 🇲🇦Morocco | — | active | — |
| LORAZEPAM PHARMA COMPRIME | 🇲🇦Morocco | — | active | — |
| TEMESTA comprimé sécable / 1 mg | 🇸🇳Senegal | WYETH LEDERLE | active | — |
| TEMESTA 2,5MG CP SEC BTE(2 X 15) NEURAXPHARM comprimé sécable, Boite de | 🇲🇬Madagascar | NEURAXPHARM France | active | — |
| TEMESTA COMPRIME SECABLE | 🇲🇦Morocco | — | active | — |
| TEMESTA comprime / 2,5 mg | 🇸🇳Senegal | NEURAXPHARMA | active | — |
| TEMESTA comprime / 2,5 mg | 🇸🇳Senegal | NEURAXPHARMA | active | — |
| LORAZEPAM PHARMA COMPRIME | 🇲🇦Morocco | — | active | — |
| TEMESTA 1MG CP SEC BTE(2 X 15) NEURAXPHARM comprimé sécable, Boite de | 🇲🇬Madagascar | NEURAXPHARM France | active | — |
| TEMESTA 1MG CP SEC BTE(2 X 15) NEURAXPHARM comprimé sécable, Boite de | 🇲🇬Madagascar | NEURAXPHARM France | active | — |
| TEMESTA 2,5MG CP SEC BTE(2 X 15) NEURAXPHARM comprimé sécable, Boite de | 🇲🇬Madagascar | NEURAXPHARM France | active | — |
LORAZEPAM in Africa — Regulatory Overview
LORAZEPAM is registered across 8 African markets with 26 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Madagascar, Morocco, Senegal and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 26 registrations, 20 (77%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.